Testing and Control Strategies for Container Closure Integrity

Available on: June 25, 2025
10:00 AM ET / 9:00 AM CT / 7:00 AM PT / 2:00 PM GMT
Sponsor: Lighthouse Instruments B.V.
Register Today!
Duration: 1 hour
Summary
Best practices for assuring container closure integrity have and will continue to evolve in response to the implementation of the revised EU GMP Annex 1 and the announced revision of the USP Package Integrity Evaluation – Sterile Products chapter. In addition, the continued development of novel therapies (cell & gene therapies) as well as the increased use of complex delivery systems such as autoinjectors, have required new approaches and methods for container closure integrity (CCI) testing.
This presentation uses industry case study examples to describe how pharmaceutical facilities are defining strategies and evolving best practices to comply with new container closure requirements. The case studies illustrate various topics including the validation of container closure integrity test methods for novel therapies and containers, generating CCI data in a product life cycle approach, and the choice to perform 100% leak detection vs. sampling in commercial manufacturing.
Speakers
Sponsored by: